[Establishment of a cellular model with human NADH-cytochrome b5 reductase deficiency via RNA interference].
OBJECTIVE
To establish a cell line with human NADH-cytochrome b5 reductase (b5R) deficiency via RNA interference (RNAi).


METHODS
Two siRNA expressing vectors targeting the b5R mRNA were designed and constructed. Hepatocellular carcinoma BEL-7402 cells were transiently transfected with the two recombinants by lipofectamine (TM) 2000, and semi-quantitative RT-PCR was carried out to analyze the suppression of b5R mRNA; BEL-7402 cells stably transfected with the two siRNA expressing vectors were selected in the media with G418. By analyses of the mRNA, enzymatic activity and protein level of b5R, several cell clones with deficiency of b5R were established. The cell growth curve of BEL-7402 cells with b5R deficiency was detected by MTT assay.


RESULTS
Two siRNA expressing vectors targeting b5R mRNA were obtained, namely pSib5R-1 and pSib5R-2. When BEL-7402 cells were transfected transiently with pSib5R-2, the expression of b5R mRNA was significantly suppressed with a suppression ratio of 68.3%, indicating that pSib5R-2 could trigger the degradation of b5R mRNA effectively. Eighteen clones stably integrated exogenous plasmids were obtained. In two clones from pSib5R-2 transfection, the expression of b5R mRNA was suppressed by up to 48.2% and 56.2%, and the enzymatic activity was inhibited by up to 54.6% and 63.5%, respectively. The protein levels also decreased significantly. The defect of b5R did not change the cell growth rate.


CONCLUSIONS
The expression of b5R in BEL-7402 could be suppressed by vector-based RNA interference effectively. We established a cellular model with defect of b5R successfully, which can be used as a tool in investigation of the biological function of b5R and molecular mechanism of type II recessive congenital methemoglobinemia.
Zhuang
Yuepeng
Y
Center for Laboratory Medicine, the Second Minitary Medical University, Fuzhou General Hospital, Fuzhou, Fujian, 350025 People's Republic of China.
Wang
Shuiliang
S
Lan
Fenghua
F
D018929:Cell Culture Techniques; D045744:Cell Line, Tumor / Q000201:enzymology; D002477:Cells / Q000201:enzymology; D042966:Cytochrome-B(5) Reductase / Q000172:deficiency* / Q000235:genetics; D015870:Gene Expression / Q000187:drug effects*; D005822:Genetic Vectors; D006801:Humans; D034622:RNA Interference / Q000502:physiology*; D012333:RNA, Messenger / Q000378:metabolism; D034741:RNA, Small Interfering / Q000494:pharmacology*; D014162:Transfection
D012333:RNA, Messenger; D034741:RNA, Small Interfering; D042966:Cytochrome-B(5) Reductase